Young-Suk Lim

机构：Ulsan College, Asan Medical Center, University of Ulsan

发表论文 12 篇 · 总被引 1071 次 · h-index 6

代表论文

• Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials (2020 · Journal of Hepatology · 被引 491)
• Update on the treatment navigation for functional cure of chronic hepatitis B: Expert consensus 2.0 (2025 · Clinical and Molecular Hepatology · 被引 29)
• Preliminary safety and antiviral activity of VIR-2218, an X-targeting HBV RNAi therapeutic, in chronic hepatitis B patients (2020 · Journal of Hepatology · 被引 28)
• PS-078-A phase 1b evaluation of HepTcell HBV-specific immunotherapy in nuc-controlled, eAg negative chronic HBV infection (2019 · Journal of Hepatology · 被引 20)
• RO7062931 antisense oligonucleotide phase 1 study demonstrates target engagement in patients with chronic hepatitis B on established nucleos(t)ide therapy (2020 · Journal of Hepatology · 被引 8)
• Phase 1b/2a study of heterologous ChAdOx1-HBV/MVA-HBV immunotherapy (VTP-300) combined with low-dose nivolumab (LDN) in virally suppressed patients with CHB on nucleos (t)ide analogues (2023 · Journal of Hepatology · 被引 3)